drugset / Trial / NCT03082482

Smartphone-delivered Automated Video-assisted Smoking Treatment for People Living With HIV

NCT03082482

Completed 20 enrolled University of Oklahoma
RandomizedParallel-groupOpen-labelTreatment

Summary

The proposed pilot study seeks to address the smoking treatment needs of people living with HIV/AIDS (PLWHA) by evaluating the feasibility and preliminary efficacy of a smartphone delivered automated video-assisted smoking treatment (AVAST). AVAST will enable smoking cessation treatment content to be presented with voice/audio, images, videos, and text in an interactive, structured format anytime and anywhere. This automated treatment approach is designed to enhance treatment engagement and facilitate abstinence from smoking among PLWHA. Participants will be recruited from the University of Oklahoma Health Sciences Center (OUHSC) clinics providing care to HIV+ individuals (e.g., the Infectious Diseases Institute).

Timeline

Start
2017-05-15
Primary completion
2017-05-19
Completion
2017-12-31

Drugs

EvaluationDrugModalityDoseRoute
Background Nicotine Unknown 14 mg Other
Background Nicotine Unknown 21 mg Other

Indications

No indication recorded.